Boehringer Ingelheim a

Boehringer Ingelheim and MiNA Therapeutics partner on the development of novel compounds to treat fibrotic liver diseases

Collaboration and licensing agreement focused on investigating up to three targets and has a potential transactional value of up to…

6 years ago